Anika Therapeutics, Inc. (ANIK)
USD 14.13
(-3.81%)
USD 14.13
(-3.81%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 166.66 Million USD | 6.67% |
| 2022 | 156.23 Million USD | 5.71% |
| 2021 | 147.79 Million USD | 13.29% |
| 2020 | 130.45 Million USD | 13.83% |
| 2019 | 114.61 Million USD | 8.58% |
| 2018 | 105.55 Million USD | -6.93% |
| 2017 | 113.42 Million USD | 9.71% |
| 2016 | 103.37 Million USD | 11.16% |
| 2015 | 92.99 Million USD | -11.93% |
| 2014 | 105.59 Million USD | 40.64% |
| 2013 | 75.08 Million USD | 5.22% |
| 2012 | 71.35 Million USD | 10.16% |
| 2011 | 64.77 Million USD | 16.6% |
| 2010 | 55.55 Million USD | 38.42% |
| 2009 | 40.13 Million USD | 12.17% |
| 2008 | 35.77 Million USD | 16.06% |
| 2007 | 30.82 Million USD | 14.86% |
| 2006 | 26.84 Million USD | -10.04% |
| 2005 | 29.83 Million USD | 12.73% |
| 2004 | 26.46 Million USD | 71.81% |
| 2003 | 15.4 Million USD | 16.81% |
| 2002 | 13.18 Million USD | 16.57% |
| 2001 | 11.31 Million USD | -30.75% |
| 2000 | 16.33 Million USD | 21.0% |
| 1999 | 13.5 Million USD | -2.88% |
| 1998 | 13.9 Million USD | 15.83% |
| 1997 | 12 Million USD | 900.0% |
| 1996 | 1.2 Million USD | -64.71% |
| 1995 | 3.4 Million USD | -27.66% |
| 1994 | 4.7 Million USD | 113.64% |
| 1993 | 2.2 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 40.52 Million USD | -5.7% |
| 2024 Q2 | 41.92 Million USD | 3.45% |
| 2024 Q3 | 38.75 Million USD | -7.56% |
| 2023 FY | 166.66 Million USD | 6.67% |
| 2023 Q1 | 37.92 Million USD | -4.29% |
| 2023 Q2 | 44.3 Million USD | 16.82% |
| 2023 Q4 | 42.97 Million USD | 3.63% |
| 2023 Q3 | 41.46 Million USD | -6.4% |
| 2022 Q1 | 36.69 Million USD | 2.43% |
| 2022 Q2 | 39.65 Million USD | 8.08% |
| 2022 FY | 156.23 Million USD | 5.71% |
| 2022 Q3 | 40.26 Million USD | 1.53% |
| 2022 Q4 | 39.62 Million USD | -1.59% |
| 2021 Q2 | 38.14 Million USD | 11.24% |
| 2021 FY | 147.79 Million USD | 13.29% |
| 2021 Q4 | 35.82 Million USD | -9.4% |
| 2021 Q1 | 34.29 Million USD | 4.91% |
| 2021 Q3 | 39.53 Million USD | 3.65% |
| 2020 FY | 130.45 Million USD | 13.83% |
| 2020 Q1 | 35.39 Million USD | 18.89% |
| 2020 Q2 | 30.67 Million USD | -13.33% |
| 2020 Q4 | 32.68 Million USD | 3.14% |
| 2020 Q3 | 31.69 Million USD | 3.31% |
| 2019 FY | 114.61 Million USD | 8.58% |
| 2019 Q1 | 24.72 Million USD | -8.28% |
| 2019 Q2 | 30.41 Million USD | 23.04% |
| 2019 Q3 | 29.69 Million USD | -2.37% |
| 2019 Q4 | 29.77 Million USD | 0.25% |
| 2018 FY | 105.55 Million USD | -6.93% |
| 2018 Q4 | 26.95 Million USD | 0.63% |
| 2018 Q1 | 21.26 Million USD | -27.64% |
| 2018 Q3 | 26.78 Million USD | -12.31% |
| 2018 Q2 | 30.54 Million USD | 43.66% |
| 2017 Q4 | 29.38 Million USD | 8.11% |
| 2017 Q2 | 33.46 Million USD | 43.09% |
| 2017 Q1 | 23.38 Million USD | -18.59% |
| 2017 Q3 | 27.18 Million USD | -18.76% |
| 2017 FY | 113.42 Million USD | 9.71% |
| 2016 FY | 103.37 Million USD | 11.16% |
| 2016 Q4 | 28.72 Million USD | 11.39% |
| 2016 Q3 | 25.78 Million USD | -2.98% |
| 2016 Q2 | 26.58 Million USD | 19.29% |
| 2016 Q1 | 22.28 Million USD | -27.87% |
| 2015 Q4 | 30.89 Million USD | 30.46% |
| 2015 Q2 | 22.9 Million USD | 47.57% |
| 2015 Q1 | 15.52 Million USD | -33.26% |
| 2015 FY | 92.99 Million USD | -11.93% |
| 2015 Q3 | 23.68 Million USD | 3.4% |
| 2014 Q4 | 23.25 Million USD | 5.44% |
| 2014 Q3 | 22.05 Million USD | -16.06% |
| 2014 FY | 105.59 Million USD | 40.64% |
| 2014 Q1 | 34.01 Million USD | 60.04% |
| 2014 Q2 | 26.27 Million USD | -22.74% |
| 2013 FY | 75.08 Million USD | 5.22% |
| 2013 Q4 | 21.25 Million USD | 19.7% |
| 2013 Q3 | 17.75 Million USD | -14.76% |
| 2013 Q2 | 20.82 Million USD | 36.61% |
| 2013 Q1 | 15.24 Million USD | -32.55% |
| 2012 Q1 | 14.36 Million USD | -22.14% |
| 2012 Q4 | 22.6 Million USD | 53.09% |
| 2012 FY | 71.35 Million USD | 10.16% |
| 2012 Q3 | 14.76 Million USD | -24.76% |
| 2012 Q2 | 19.62 Million USD | 36.66% |
| 2011 Q1 | 11.73 Million USD | -20.27% |
| 2011 Q4 | 18.44 Million USD | -0.06% |
| 2011 FY | 64.77 Million USD | 16.6% |
| 2011 Q2 | 16.14 Million USD | 37.51% |
| 2011 Q3 | 18.45 Million USD | 14.34% |
| 2010 FY | 55.55 Million USD | 38.42% |
| 2010 Q3 | 13.86 Million USD | -4.35% |
| 2010 Q2 | 14.49 Million USD | 16.31% |
| 2010 Q4 | 14.72 Million USD | 6.15% |
| 2010 Q1 | 12.46 Million USD | 17.39% |
| 2009 Q2 | 9.52 Million USD | 3.51% |
| 2009 Q1 | 9.2 Million USD | 2.62% |
| 2009 FY | 40.13 Million USD | 12.17% |
| 2009 Q3 | 10.79 Million USD | 13.33% |
| 2009 Q4 | 10.61 Million USD | -1.61% |
| 2008 Q1 | 8.54 Million USD | -11.2% |
| 2008 Q4 | 8.96 Million USD | -2.6% |
| 2008 Q3 | 9.2 Million USD | 1.6% |
| 2008 FY | 35.77 Million USD | 16.06% |
| 2008 Q2 | 9.06 Million USD | 5.98% |
| 2007 Q2 | 7.09 Million USD | 15.66% |
| 2007 FY | 30.82 Million USD | 14.86% |
| 2007 Q4 | 9.62 Million USD | 20.86% |
| 2007 Q3 | 7.96 Million USD | 12.2% |
| 2007 Q1 | 6.13 Million USD | 4.23% |
| 2006 Q2 | 7.79 Million USD | 12.15% |
| 2006 Q4 | 5.88 Million USD | -5.03% |
| 2006 Q3 | 6.2 Million USD | -20.48% |
| 2006 Q1 | 6.95 Million USD | 27.2% |
| 2006 FY | 26.84 Million USD | -10.04% |
| 2005 FY | 29.83 Million USD | 12.73% |
| 2005 Q4 | 5.46 Million USD | -45.66% |
| 2005 Q3 | 10.05 Million USD | 43.28% |
| 2005 Q2 | 7.02 Million USD | -3.72% |
| 2005 Q1 | 7.29 Million USD | -4.77% |
| 2004 Q2 | 6.26 Million USD | 1.97% |
| 2004 FY | 26.46 Million USD | 71.81% |
| 2004 Q4 | 7.65 Million USD | 19.49% |
| 2004 Q3 | 6.4 Million USD | 2.32% |
| 2004 Q1 | 6.14 Million USD | 22.48% |
| 2003 Q1 | 3.38 Million USD | -18.34% |
| 2003 FY | 15.4 Million USD | 16.81% |
| 2003 Q4 | 5.01 Million USD | 35.95% |
| 2003 Q3 | 3.68 Million USD | 11.15% |
| 2003 Q2 | 3.31 Million USD | -1.95% |
| 2002 Q3 | 3.23 Million USD | -5.52% |
| 2002 FY | 13.18 Million USD | 16.57% |
| 2002 Q1 | 2.38 Million USD | -24.39% |
| 2002 Q2 | 3.42 Million USD | 43.15% |
| 2002 Q4 | 4.14 Million USD | 28.22% |
| 2001 FY | 11.31 Million USD | -30.75% |
| 2001 Q4 | 3.16 Million USD | 3.5% |
| 2001 Q3 | 3.05 Million USD | 4.62% |
| 2001 Q1 | 2.17 Million USD | -69.38% |
| 2001 Q2 | 2.91 Million USD | 33.99% |
| 2000 Q4 | 7.11 Million USD | 160.67% |
| 2000 FY | 16.33 Million USD | 21.0% |
| 2000 Q3 | 2.72 Million USD | -27.57% |
| 2000 Q2 | 3.76 Million USD | 38.52% |
| 2000 Q1 | 2.72 Million USD | -9.31% |
| 1999 Q3 | 3.5 Million USD | -7.89% |
| 1999 Q2 | 3.8 Million USD | 18.75% |
| 1999 FY | 13.5 Million USD | -2.88% |
| 1999 Q1 | 3.2 Million USD | -5.88% |
| 1999 Q4 | 3 Million USD | -14.29% |
| 1998 Q2 | 4.6 Million USD | 64.29% |
| 1998 Q3 | 3.2 Million USD | -30.43% |
| 1998 Q4 | 3.4 Million USD | 6.25% |
| 1998 Q1 | 2.8 Million USD | -53.33% |
| 1998 FY | 13.9 Million USD | 15.83% |
| 1997 Q1 | 1.9 Million USD | 72.73% |
| 1997 Q3 | 1.6 Million USD | -36.0% |
| 1997 FY | 12 Million USD | 900.0% |
| 1997 Q2 | 2.5 Million USD | 31.58% |
| 1997 Q4 | 6 Million USD | 275.0% |
| 1996 Q4 | 1.1 Million USD | -15.38% |
| 1996 Q3 | 1.3 Million USD | -13.33% |
| 1996 Q2 | 1.5 Million USD | 50.0% |
| 1996 Q1 | 1 Million USD | 11.11% |
| 1996 FY | 1.2 Million USD | -64.71% |
| 1995 FY | 3.4 Million USD | -27.66% |
| 1995 Q2 | 900 Thousand USD | 28.57% |
| 1995 Q4 | 900 Thousand USD | 0.0% |
| 1995 Q3 | 900 Thousand USD | 0.0% |
| 1995 Q1 | 700 Thousand USD | -22.22% |
| 1994 Q2 | 1 Million USD | -28.57% |
| 1994 Q4 | 900 Thousand USD | -18.18% |
| 1994 Q3 | 1.1 Million USD | 10.0% |
| 1994 FY | 4.7 Million USD | 113.64% |
| 1994 Q1 | 1.4 Million USD | 16.67% |
| 1993 FY | 2.2 Million USD | 0.0% |
| 1993 Q3 | 2.1 Million USD | 2000.0% |
| 1993 Q2 | 100 Thousand USD | 0.0% |
| 1993 Q4 | 1.2 Million USD | -42.86% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 12.05 Million USD | -1282.055% |
| BrainsWay Ltd. | 31.78 Million USD | -424.342% |
| Cerus Corporation | 156.36 Million USD | -6.584% |
| Envoy Medical, Inc. | 316 Thousand USD | -52641.139% |
| electroCore, Inc. | 16.03 Million USD | -939.688% |
| Helius Medical Technologies, Inc. | 644 Thousand USD | -25779.193% |
| IceCure Medical Ltd | 3.22 Million USD | -5061.412% |
| Inogen, Inc. | 315.66 Million USD | 47.202% |
| OrthoPediatrics Corp. | 148.73 Million USD | -12.055% |
| Lucid Diagnostics Inc. | 2.42 Million USD | -6764.168% |
| Monogram Orthopaedics, Inc. | 364.99 Thousand USD | -45560.947% |
| MaxCyte, Inc. | 41.28 Million USD | -303.657% |
| NeuroOne Medical Technologies Corporation | 1.95 Million USD | -8436.084% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -150387.593% |
| Orthofix Medical Inc. | 746.64 Million USD | 77.678% |
| PAVmed Inc | 2.45 Million USD | -6696.982% |
| Rapid Micro Biosystems, Inc. | 22.51 Million USD | -640.095% |
| RxSight, Inc. | 89.07 Million USD | -87.099% |
| Sight Sciences, Inc. | 81.05 Million USD | -105.613% |
| SI-BONE, Inc. | 138.88 Million USD | -19.999% |
| TELA Bio, Inc. | 58.45 Million USD | -185.121% |
| Treace Medical Concepts, Inc. | 187.11 Million USD | 10.932% |
| Vivos Therapeutics, Inc. | 13.8 Million USD | -1107.608% |
| Acutus Medical, Inc. | 7.16 Million USD | -2226.382% |
| Talis Biomedical Corporation | 412 Thousand USD | -40351.942% |
| Spectral AI, Inc. | 18.05 Million USD | -823.028% |
| Nano-X Imaging Ltd. | 9.9 Million USD | -1582.605% |
| CVRx, Inc. | 39.29 Million USD | -324.13% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 968.7 Thousand USD | -17104.601% |
| Bioventus Inc. | 512.34 Million USD | 67.471% |
| Venus Concept Inc. | 76.35 Million USD | -118.275% |
| TriSalus Life Sciences, Inc. | 18.51 Million USD | -800.34% |
| LivaNova PLC | 1.15 Billion USD | 85.552% |
| 908 Devices Inc. | 50.22 Million USD | -231.804% |
| Alphatec Holdings, Inc. | 482.26 Million USD | 65.442% |
| Nemaura Medical Inc. | 77.04 Thousand USD | -216220.544% |
| NeuroPace, Inc. | 65.42 Million USD | -154.753% |
| LENSAR, Inc. | 42.16 Million USD | -295.271% |
| Apyx Medical Corporation | 52.34 Million USD | -218.367% |
| Cutera, Inc. | 212.36 Million USD | 21.522% |
| STRATA Skin Sciences, Inc. | 33.35 Million USD | -399.616% |
| BioSig Technologies, Inc. | 18 Thousand USD | -925800.0% |
| ClearPoint Neuro, Inc. | 23.95 Million USD | -595.729% |
| Integra LifeSciences Holdings Corporation | 1.54 Billion USD | 89.189% |
| Axonics, Inc. | 366.37 Million USD | 54.511% |
| Outset Medical, Inc. | 130.37 Million USD | -27.832% |
| IRIDEX Corporation | 51.86 Million USD | -221.313% |
| PROCEPT BioRobotics Corporation | 136.19 Million USD | -22.374% |
| IRadimed Corporation | 65.56 Million USD | -154.204% |
| Tivic Health Systems, Inc. | 1.17 Million USD | -14071.939% |
| INVO Bioscience, Inc. | 3.02 Million USD | -5417.559% |
| Telesis Bio, Inc. | 27.5 Million USD | -505.845% |
| Viemed Healthcare, Inc. | 183 Million USD | 8.932% |
| Varex Imaging Corporation | 811 Million USD | 79.45% |
| Quipt Home Medical Corp. | 221.74 Million USD | 24.84% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 68.67 Million USD | -142.682% |
| Dynatronics Corporation | 32.53 Million USD | -412.271% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 8.67 Million USD | -1820.512% |
| Semler Scientific, Inc. | 68.18 Million USD | -144.43% |
| InMode Ltd. | 492.04 Million USD | 66.129% |
| Bruker Corporation | 2.96 Billion USD | 94.378% |
| Cytosorbents Corporation | 36.34 Million USD | -358.5% |
| DexCom, Inc. | 3.62 Billion USD | 95.399% |
| Align Technology, Inc. | 3.86 Billion USD | 95.685% |
| Viveve Medical, Inc. | 6.42 Million USD | -2493.557% |
| ZimVie Inc. | 457.43 Million USD | 63.566% |
| Movano Inc. | - USD | -Infinity% |
| Cytek Biosciences, Inc. | 193.01 Million USD | 13.653% |
| Nexalin Technology, Inc. | 110.74 Thousand USD | -150387.593% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 747.71 Million USD | 77.711% |
| Profound Medical Corp. | 7.33 Million USD | -2173.38% |
| Insulet Corporation | 1.69 Billion USD | 90.18% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 126.07 Million USD | -32.19% |
| iCAD, Inc. | 17.31 Million USD | -862.363% |
| Nuwellis, Inc. | 8.86 Million USD | -1780.212% |
| Biotricity, Inc. | 12.06 Million USD | -1281.557% |
| iRhythm Technologies, Inc. | 492.68 Million USD | 66.172% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 6.2 Million USD | -2585.931% |
| PAVmed Inc. | 2.45 Million USD | -6696.982% |
| BIOLASE, Inc. | 49.16 Million USD | -238.992% |
| Beyond Air, Inc. | 1.15 Million USD | -14279.81% |
| FONAR Corporation | 102.88 Million USD | -61.99% |
| AxoGen, Inc. | 159.01 Million USD | -4.811% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 274.42 Million USD | 39.268% |
| Inari Medical, Inc. | 493.63 Million USD | 66.238% |
| UFP Technologies, Inc. | 400.07 Million USD | 58.342% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 18.6 Thousand USD | -895932.258% |
| Tenon Medical, Inc. | 2.92 Million USD | -5592.008% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 6.81 Million USD | -2346.581% |
| AdaptHealth Corp. | 3.2 Billion USD | 94.792% |
| Sintx Technologies, Inc. | 2.62 Million USD | -6244.195% |
| NanoVibronix, Inc. | 2.28 Million USD | -7200.131% |
| Quanterix Corporation | 122.36 Million USD | -36.197% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 24.4 Million USD | -582.901% |
| Pacific Biosciences of California, Inc. | 200.52 Million USD | 16.886% |
| TransMedics Group, Inc. | 241.62 Million USD | 31.024% |
| ReWalk Robotics Ltd. | 13.85 Million USD | -1102.988% |
| NeuroMetrix, Inc. | 5.9 Million USD | -2724.098% |
| Hyperfine, Inc. | 11.03 Million USD | -1410.714% |
| Establishment Labs Holdings Inc. | 165.15 Million USD | -0.915% |
| Biomerica, Inc. | 5.41 Million USD | -2977.784% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 50.56 Million USD | -229.626% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 177.13 Million USD | 5.912% |